Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo ester drop pills for vascular cognitive impairment
ChiCTR2200062451Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ginkgo biloba extract in vascular cognitive disorder (VCD) (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Montreal Cognitive Assessment at 24 weeks. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on ChiCTR2200062451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062451.